Fabian Theis is a New EMBO Member
Fabian Theis, Director of the Computational Health Center at Helmholtz Munich, has been accepted for membership in the European Molecular Biology Organization (EMBO). Scientists can only be invited to join EMBO on the recommendation of existing members. This requires outstanding research results at the highest international level.
Fabian Theis is an internationally leading pioneer in the fields of machine learning in biomedicine and digital health research. He leads the Computational Health Center at Helmholtz Munich and is scientific director of the Helmholtz Artificial Intelligence Cooperation Unit (Helmholtz AI).
Theis has founded the Munich School for Data Science, which significantly strengthens the promotion of young researchers in the field of data science, and is involved in numerous international AI initiatives. In Bavaria, Theis is an integral part of the AI Council. He is a key player in the Human Cell Atlas, an international collaborative project with the goal of establishing a reference database of all human cells as a basis for the diagnosis, monitoring and therapy of diseases. Throughout his career, Theis contributed to answering medical questions such as the risk assessment of type-1-diabetes, modelling of drug combinations in diabetes, prediction of diabetic retinopathy and to solving questions facing the SARS-CoV-2 pandemic.
EMBO is a leading organization in life sciences with approx. 1,800 highly esteemed members. The organization aims to promote excellence in life sciences in Europe and around the world. EMBO members support the community through their international collaborations and network and are actively involved in the organization's projects, such as the evaluation of applications for EMBO funding, the mentoring of young scientists and by providing suggestions and feedback. New members of the organization are nominated and elected by its existing members in recognition of their outstanding scientific achievements.